Over the past decade, more and more pharma and biotech companies have turned to CROs, CMOs, and CDMOs to assist in the R&D, pre-formulation, and manufacturing of their latest innovations. Outsourcing is now a multi-billion dollar industry, and most of the spending is focused on early development, with around two-thirds of annual expenditure being outsourced. The industry’s high profit margins make it an easy target for healthcare companies to squeeze them on costs and reimbursement. Aside from costs, one of the significant reasons many pharma companies choose to outsource their R&D and manufacturing is to access technologies that are not available in-house.
Outsourcers can also offer a higher agility level, which is just not possible within large biopharma organizations. Today, CDMOs have become a vital part of the drug development and manufacturing process, with most small and medium-sized enterprises and an increasing number of big pharma relying on outsourced services. CDMOs are expected to quickly respond to new emerging challenges, particularly as drug development campaigns become increasingly complex. Besides, with complexity comes a greater need for CDMOs to provide effective process solutions as well as services and rapid innovation for delivering all of the new and sophisticated drug products. In order to attain these higher standards, CDMOs must be technologically progressive and flexible, combining professionals from multiple disciplines to actively discover solutions that increase the overall efficiency of their projects.
The CDMO landscape is continuing to perform strongly with growth ahead of the underlying market, leading to increasing market penetration. With a positive M&A environment, substantial ongoing investments, and attractive forecast growth, the industry’s future remains very positive. Highlighting these new developments in the pharmaceutical landscape, Pharma Tech Outlook has compiled a list of leading pharma outsourcing companies that are at the top of their game. The enlisted organizations are transforming the pharmaceutical manufacturing and development processes at the convergence of several disruptive technologies. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for aspiring CXOs.
We present to you Pharma Tech Outlook’s “Top 10 Emerging Pharma Outsourcing Companies - 2021”
